CROI 2023

19 - 22, February 2023

The prestigious Conference on Retroviruses and Opportunistic Infections (CROI) accelerates progress in HIV research. Open to researchers and clinical educators working in this space, the 2023 event was held in-person in Seattle, USA, from 19-22 February.

For ViiV Healthcare, CROI is a crucial forum for our efforts to leave no person living with HIV behind. Abstracts from our innovative pipeline and portfolio reinforce our commitment to the evolving needs of the HIV community. They included the first head-to-head data for our complete long-acting regimen, and new prevention findings for women.

Our data reinforced the power of science to combat HIV stigma and to improve the quality of life for people living with HIV. Watch the videos below to find out more from our colleagues and partners.


Discover the importance of representative research for HIV treatment for people living with HIV

With ViiV Healthcare’s Science on the Sofa, we’re changing how we talk about HIV science by breaking down complex concepts in a new way to make the science accessible for everyone.

As someone living with HIV, you will face challenges throughout your life, but you are strong and you will overcome every hurdle to build the life you want.

NP-GBL-HVX-COCO-230001 January 2023

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at or search for MHRA Yellowcard in the Google Play or Apple App store. By reporting side effects, you can help provide more information on the safety of this medicine.

If you are from outside the UK, you can report adverse events to GSK/ViiV by selecting your region and market, here.